NICAISE CLAUDE sold 8.2% of their position (2.49K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $248.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/13/2025ACC: 0000950170-25-039037
-2.49K
Net shares
Net seller
$248.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9.75K acquired · 12.24K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.75K
Price / share
$25.18
Trade value
$245.40K
% of position
47.4%
3/12/2025
20.56K→30.30K
Common Stock
Direct
Shares
−2.49K
Price / share
$99.64
Trade value
$248.20K
% of position
8.2%
3/12/2025
30.30K→27.81K
Total
Net shares
+7.25K
Net value
-$2.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2025 | M · Option Exercise | +9.75K | $25.18 | $245.40K | 47.4% | 20.56K | 30.30K |
| Common Stock Direct | 3/12/2025 | S · Sale | −2.49K | $99.64 | $248.20K | 8.2% | 30.30K | 27.81K |
| Total | +7.25K | -$2.80K | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Common Stock
9.75K shares
Shares
−9.75K
Strike price
25.18
Held after
0.00
Exercisable
—
3/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock9.75K shares | 3/12/2025 | M · Option Exercise | −9.75K | 25.18 | — | 0.00 |